From: Adenocarcinoma with mixed subtypes is a rare but aggressive histologic subtype in colorectal cancer
Characteristics | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
P value | HR | 95% CI | P value | |
Sex | 0.06 | |||
Male | ||||
Female | ||||
Age (yrs) | < 0.001 | 2.26 | 1.87–2.73 | < 0.001 |
≤ 66 | ||||
> 66 | ||||
Tumor location | < 0.001 | |||
Colon | ||||
Rectum | ||||
Grade | < 0.001 | 0.001 | ||
Well differentiated | 1 | Reference | ||
Moderately differentiated | 1.50 | 0.96–2.34 | 0.08 | |
Poorly differentiated or undifferentiated | 2.06 | 1.30–3.28 | 0.002 | |
TNM stage | < 0.001 | < 0.001 | ||
0 + I | 1 | Reference | ||
II | 2.04 | 1.24–3.35 | 0.01 | |
III | 5.12 | 3.23–8.09 | < 0.001 | |
IV | 15.39 | 9.55–24.79 | < 0.001 | |
Race | < 0.001 | |||
American Indian/Alaska Native | ||||
Asian or Pacific Islander | ||||
Black | ||||
White | ||||
Insurance status | < 0.001 | |||
Insured | ||||
Others | ||||
Marital status | < 0.001 | 0.003 | ||
Married | 1 | Reference | ||
Widowed | 1.40 | 1.10–1.78 | 0.01 | |
Others | 1.33 | 1.08–1.63 | 0.01 | |
CEA | < 0.001 | < 0.001 | ||
Normal | 1 | Reference | ||
Borderline | 1.43 | 0.45–4.51 | 0.54 | |
Elevated | 1.76 | 1.44–2.15 | < 0.001 | |
CRM | < 0.001 | 1.47 | 1.22–1.77 | < 0.001 |
Negative | ||||
Positive | ||||
Perineural invasion | < 0.001 | |||
Negative | ||||
Positive | ||||
Tumor deposits | < 0.001 | 1.70 | 1.39–2.08 | < 0.001 |
Absent | ||||
Present | ||||
Histologic subtype (classical adenocarcinoma as reference) | < 0.001 | < 0.001 | ||
Classical adenocarcinoma | 1 | Reference | ||
Mucinous adenocarcinoma | 1.14 | 0.93–1.39 | 0.20 | |
Signet-ring cell carcinoma | 1.88 | 1.37–2.58 | < 0.001 | |
Adenocarcinoma with mixed subtypes | 1.89 | 1.25–2.85 | 0.003 | |
Histologic subtype (adenocarcinoma with mixed subtypes as reference) | < 0.001 | < 0.001 | ||
Adenocarcinoma with mixed subtypes | 1 | Reference | ||
Classical adenocarcinoma | 0.53 | 0.35–0.81 | 0.003 | |
Mucinous adenocarcinoma | 0.60 | 0.40–0.90 | 0.01 | |
Signet-ring cell carcinoma | 0.99 | 0.65–1.53 | 0.98 |